This clinical trial aimed to provide evidence on the efficacy and safety of pramipexole in patients with uremic RLS receiving peritoneal dialysis (PD). Methods and analysis This is a 12-week, ...

Review the side-effects of Pramipexole as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

The drugs that are used first to treat restless legs syndrome most often include ropinirole, pramipexole, and rotigotine. The drug gabapentin enacarbil is also used, but usually only when the ...

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomized, double-blind, placebo-controlled trial. Lancet Neurol. 9 , 573–580 (2010). Article CAS ...

Pramipexole dihydrochloride extended-release 0.375mg, 0.75mg, 1.5mg, 2.25mg, 3mg, 3.75mg, 4.5mg; tabs. Swallow whole. May take with food. Initially 0.375mg once daily ...

Her symptoms were relieved and she did not suffer any motor fluctuation. The drug was adjusted to sinemet (levodopa/carbidopa) 200/50 mg three times daily and pramipexole 0.25 mg three times daily 9 ...

Sifrol ER works by having a similar effect as dopamine in the brain. Sifrol ER contains the active ingredient pramipexole dihydrochloride monohydrate. It belongs to a group of medicines known as ...

metab.kuhp.kyoto-u.ac.jp Objective We investigated the prevalence of restless legs syndrome (RLS) in Japanese patients with type 2 diabetes and assessed the efficacy of pramipexole therapy. Design One ...

case number 07-cv-00457-SLR Terminal disclaimers and obviousness-type double patenting Boehringer Ingelheim's Mirapex (pramipexole) has been at the centre of a case that looked at when terminal ...

Parkinson's disease dementia (PDD) is a feature of Parkinson's disease, a progressive movement disorder associated with both motor (movement-related) and nonmotor symptoms. Dementia causes ...